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Synaptotagmins are membrane proteins that possess
tandem C2 domains and play an important role in reg-
ulated membrane fusion in metazoan organisms. Here
we show that both synaptotagmins I and II, the two
major neuronal isoforms, can interact with the syntaxin/
synaptosomal-associated protein of 25 kDa (SNAP-25)
dimer, the immediate precursor of the soluble NSF at-
tachment protein receptor (SNARE) fusion complex. A
stretch of basic amino acids highly conserved through-
out the animal kingdom is responsible for this calcium-
independent interaction. Inositol hexakisphosphate
modulates synaptotagmin coupling to the syntaxin/
SNAP-25 dimer, which is mirrored by changes in chro-
maffin cell exocytosis. Our results shed new light on the
functional importance of the conserved polybasic syn-
aptotagmin motif, suggesting that synaptotagmin inter-
acts with the t-SNARE dimer to up-regulate the proba-
bility of SNARE-mediated membrane fusion.
Cell-cell communication relies on the regulated release of
transmitter molecules from secretory vesicles. These vesicles
fuse with the plasma membrane in a calcium-dependent man-
ner to release the transmitter molecules (1, 2). Despite identi-
fication of the major players involved in intracellular mem-
brane fusion (3, 4), the molecular steps leading to vesicle fusion
are still not fully understood. Synaptotagmin I, a calcium-
phospholipid binding protein, is essential for synchronous syn-
aptic vesicle exocytosis, whereas membrane fusion itself relies
on the three SNARE1 proteins: synaptobrevin, also known as
vesicle-associated membrane protein or VAMP, on the vesicu-
lar membrane, and syntaxin and SNAP-25, on the target
plasma membrane (5–8). The three SNARE proteins form a
four-helical bundle that likely drives membrane fusion (9), with
the syntaxin/SNAP-25 dimer (t-SNARE dimer) being an impor-
tant intermediate in this process (10, 11).
Current models of calcium-triggered exocytosis depict the
calcium sensor, synaptotagmin, being physically linked to the
SNARE fusion machinery in anticipation of the calcium entry
(12–15). Indeed, many independent studies have demonstrated
that synaptotagmin I, the major brain isoform, can interact
specifically with the neuronal SNAREs in the absence of cal-
cium, as evidenced by pull-downs and affinity chromatography
approaches followed by Coomassie staining (16–20). Using the
brain-purified SNAREs, syntaxin1 and SNAP-25, we were re-
cently able to show that synaptotagmin I binds specifically and
with high affinity the t-SNARE dimer (but not the monomeric
SNARE proteins) in a calcium-independent manner (18). Fur-
thermore, we found that the majority of syntaxin and SNAP-25
in neuroendocrine cells likely exist as stable t-SNARE dimers
on the plasma membrane (11), suggesting that interaction of
vesicular synaptotagmin with this entity may take place dur-
ing the SNARE-mediated fusion of the two membranes.
Because it is well established that synaptotagmin I plays a
critical role in SNARE-mediated membrane fusion (3, 6, 7), the
molecular basis for the observed calcium-independent physical
link between synaptotagmin and SNAREs must be elucidated.
All synaptotagmins possess tandem C2 domains connected to
the transmembrane region through a variable length linker
(21), and it is these domains in synaptotagmin I that are
responsible for the calcium-independent SNARE binding (18).
Here, we analyzed the synaptotagmin/SNARE link using
genomic information of synaptotagmin amino acid sequences,
the available structures of the individual C2 domains (22, 23),
and biochemical/mutagenesis studies. We now show that lysine
residues in the fourth -strand of the C2B domain of synapto-
tagmins I and II are essential for binding to the t-SNARE
dimer. The almost complete conservation of this polybasic motif
throughout evolution and between the two major members of
the synaptotagmin family highlights its importance in exocy-
tosis. Our functional analysis of the calcium-independent syn-
aptotagmin/SNARE link suggests that this interaction serves a
positive role in vesicle exocytosis and may be regulated by
inositol polyphosphates.
EXPERIMENTAL PROCEDURES
Cloning of Synaptotagmin Isoforms and Their Mutants—RT-PCR of
rat brain mRNA was used to produce GST fusion clones in pGEX-KG
corresponding to synaptotagmins I (amino acids 95–421) and II (amino
acids 101–422). The individual C2 domains of synaptotagmin I and the
synaptotagmin II C2B mutations were described previously (18, 24).
For amperometry, synaptotagmin I C2AB construct (residues 96–421)
in pcDNA3.1 was used. Site-directed mutagenesis was performed with
the QuikChange system (Stratagene) to generate the K326A,K327A,
D178N,D230N,D232N, and D363N,D365N mutations in the synapto-
tagmin I C2AB in pcDNA3.1. Similar levels of eukaryotic expression for
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synaptotagmin and its mutants were confirmed in HeLa cells by West-
ern immunoblotting. To transfer the K326A,K327A mutation into a
GST fusion, the wild-type Kpn-Pst fragment in synaptotagmin I
pGEX-KG was substituted with the Kpn-Pst fragment from the mutant
synaptotagmin I in pcDNA3.1.
Preparation of Proteins and Binding Assays—Recombinant synapto-
tagmin fragments, purified on glutathione-Sepharose beads (Amer-
sham Biosciences) were washed with buffer A (20 mM HEPES, pH 7.0,
100 mM NaCl, 2 mM EDTA) adjusted to 1 M NaCl and 1 mM dithiothre-
itol before elution with 15 mM reduced glutathione in buffer A. Proteins
were bound to heparin-Sepharose (Amersham Biosciences), eluted us-
ing a linear gradient (0.1–1.2 M NaCl) in buffer A, and dialyzed against
buffer A. Syntaxin and SNAP-25 were purified from bovine brain cor-
tex, as described previously (25). All synaptotagmin/SNARE binding
reactions were performed in the absence of calcium. Synaptotagmin
domains (3 g each) attached to glutathione-Sepharose beads were
incubated for 30 min at 22 °C in 100 l buffer A in the presence of 1 M
SNAREs. Beads were washed three times with 1 ml of buffer A, and
bound protein was analyzed by SDS-PAGE and Coomassie staining. For
Western immunoblotting, 0.5% of bound material was run on SDS-
PAGE followed by transfer to polyvinylidene difluoride membrane (Mil-
lipore). Protein bands were detected by using monoclonal antibodies to
SNAP-25 (SMI 81, Sternberger Monoclonals) and syntaxin (HPC-1,
Sigma) and enhanced chemiluminescence with exposure to x-ray film.
For screening the synaptotagmin II C2B mutations, densitometric
quantitation of bands on x-ray film was performed and normalized
against the GST-C2B amounts used in each reaction. Phospholipid
binding was performed as described previously (26), except that
phosphatidylcholine/phosphatidylserine liposomes were labeled with
0.2% (w/w) DiO fluorescent dye (Molecular Probes), and bound fluores-
cence was measured using a microplate fluorimeter (Fluoroskan,
Labsystems).
Genomic Synaptotagmin Sequences—Synaptotagmin I orthologs
were predicted from genome sequences and correspond to the following
reference nucleotide sequences: Homo sapiens, cDNA sequence
m55047; Caenorhabditis elegans, cDNA sequence l15302; Anopheles
gambiae, whole genome contig aaab01008964.1 (nucleotides 9168323–
9168173, 9167627–9167347, 9167063–9166965, 9166862–9166668,
9166206–9166030, 9162205–9162088, 9161907–9161774, 9159169–
9158981); Drosophila melanogaster, genome sequence contig
ae003582.3 (259206 –258966, 258905–258646, 258588 –258493,
257994–257800, 257689–257513, 252486–252372, 250990–250857,
248592–248389); Ciona intestinalis, scaffold 152 (33210–33369, 33527–
33708, 34123–34230, 34456 –34530, 34853–34945, 35533–35706,
36206–36349, 36888–36992, 37206–37385).
Synaptotagmin/SNARE Immunoprecipitation from Rat Brain—All
procedures were performed at 4 °C. One rat brain was homogenized in
12 ml of buffer A using a glass Teflon homogenizer, and membrane
protein was solubilized by the addition of 2% Triton X-100 in the
presence of Complete protease inhibitors (Roche Applied Science). The
brain detergent extract was cleared by centrifugation at 100,000 g for
1 h. Anti-SNAP-25 beads were prepared as described previously (18).
The beads, with or without attached anti-SNAP-25 (SMI81, Stern-
berger Monoclonals), were incubated with the brain extract for 1 h and
washed extensively in either 20 mM HEPES, pH 7.0, 100 mM NaCl, 2
mM EDTA, 0.1% Triton X-100, or in 20 mM HEPES, pH 7.0, 750 mM
NaCl, 2 mM EDTA, 0.1% Triton X-100. The bound proteins were ana-
lyzed by Western immunoblotting using antibodies that specifically
stain synaptotagmin I (clone 41.1, Synaptic Systems), synaptotagmin II
(monoclonal antibody against the luminal part of the protein; Ref. 27),
calcineurin (clone CN-A1, Sigma), and polyclonal anti-syntaxin and
anti-SNAP-25. The immunoreactive bands were detected by enhanced
chemiluminescence and visualized by using a Bio-Rad XRS detection
system.
Catecholamine Release Assays—For amperometry analysis, chromaf-
fin cells were transfected by electroporation with plasmids encoding the
cytoplasmic part (C2AB) of synaptotagmin I and enhanced green fluo-
rescent protein (EGFP), as described previously (28). Three days after
electroporation, the transfected cells were identified with a Nikon
TE300 inverted microscope. A carbon fiber electrode was positioned in
contact with a cell, and stimulation was by pressure ejection of buffer B
(139 mM potassium glutamate, 20 mM PIPES, 5 mM EGTA, 2 mM ATP,
2 mM MgCl2, pH 6.5) containing 20 M digitonin and 10 M free Ca
2 for
a 20-s pulse. Amperometric responses were monitored with a VA-10
amplifier (NPI Electronic), collected at 4 kHz, and digitized with a
Digidata 1322A acquisition system. Data were analyzed by using the
program Origin (Microcal) (28) and are shown as mean  S.E. In each
series of experiments, EGFP-negative control cells, in the same dishes,
were recorded, using the same carbon-fibers. The permeabilization of
chromaffin cells and fluorescent assay for catecholamine release were
done as described previously (29). Briefly, chromaffin cells were incu-
bated with 20 M digitonin in buffer B for 5 min with or without IP6.
The supernatant was discarded, and release was triggered for 5 min in
buffer B containing 20 M free Ca2 in the absence or presence of IP6.
Aliquots of the supernatant were assayed fluorometrically for cate-
cholamine content (30). Released catecholamine was expressed as a
normalized percentage to the release obtained in the absence of IP6.
Confocal Microscopy—Chromaffin cells seeded on polylysine-coated
bottom glass coverslip dishes (Mattek) were permeabilized with 20 M
digitonin in buffer B for 5 min with GST-C2B of synaptotagmin I (130
nM) or GST (150 nM) in the absence or presence of 200 M IP6. After a
15-min incubation, cells were washed, fixed with 4% paraformaldehyde
for 20 min, and then blocked for 1 h in phosphate-buffered saline
containing 3% goat serum and 0.05% Triton X-100. Incubation with
anti-SNAP-25 monoclonal antibody was followed by a phosphate-buff-
ered saline wash. SNAP-25 and bound exogenous GST were visualized
using Alexa594 anti-mouse and Alexa488 anti-GST, respectively. Im-
ages were collected on a Bio-Rad 600 confocal microscope using an
oil-immersion objective (63/1.4 numerical aperture). Fluorescence in-
tensity was quantified by using the LaserPix software (Bio-Rad).
RESULTS
The absence of structural information for the synaptotagmin/
SNARE complex currently hinders analysis of this potentially
important interaction. We analyzed the molecular basis of this
link by using functional assays that rely on the stoichiometric,
high-affinity binding of synaptotagmin to the target SNARE
dimer (Fig. 1A; Ref. 18). Binding of the cytoplasmic part of
synaptotagmin, C2AB, to the target SNAREs was sensitive to
ionic strength, indicating that it is of an electrostatic nature
(Fig. 1A). Both syntaxin and SNAP-25 contribute acidic resi-
dues to a negatively charged surface on the ternary SNARE
complex (9), suggesting that basic residues on synaptotagmin
may be responsible for interaction with the t-SNARE dimer.
Analysis of the surface charge of the two C2 domains of syn-
aptotagmin I (22, 23) revealed a prominent patch of basic
residues present on the C2B domain (Fig. 1B). This positively
charged patch is due to a high concentration of lysines in the
fourth strand of the C2B -sandwich structure (23). Compari-
son of synaptotagmin I sequences from worms, insects, a prim-
itive chordate Ciona, and humans, assembled from genomic
databases, revealed that the polybasic amino acid stretch is
virtually identical in all animal species, despite the fact that
conservation of the whole synaptotagmin sequence is in the
range of only 50–65% (Fig. 1C and data not shown). This
observation strongly suggests an essential role for the C2B
polybasic motif.
We investigated whether the C2B domain is indeed sufficient
for binding the t-SNARE dimer. Recent reports demonstrated
that the functional properties of the bacterially expressed C2B
domain are altered by bacterial contaminants such as nucleic
acids (23, 31). The C2B domain, isolated by a single affinity
chromatography step from bacterial extracts, does not bind the
t-SNARE dimer (18). Therefore, the recombinant C2A and C2B
domains, although pure by SDS-PAGE, were thoroughly
washed in 1 M NaCl to remove any contaminants. After wash-
ing, C2B but not C2A bound to the t-SNARE dimer in a calci-
um-independent manner (Fig. 1D). Importantly, neither C2
domain was able to interact with monomeric syntaxin or
SNAP-25. Therefore, the C2B domain binds the t-SNAREs
through the same mechanism as for native synaptotagmin I
(18).
The C2B polybasic motif has been shown to bind inositol
polyphosphates, including inositol hexakisphosphate (IP6) (24).
Because IP6 can potently inhibit synaptic vesicle exocytosis
2 v1.0 genome assembly is available on the Internet at
genome.jgi-psf.org/ciona4/ciona4.home.html.
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(32), we analyzed whether IP6 may have an effect on the syn-
aptotagmin/SNARE interaction. IP6 strongly suppressed syn-
aptotagmin binding to the t-SNARE dimer with an IC50 of 6 M
(Fig. 2A), indicating that the conserved polybasic motif is re-
sponsible for SNARE binding. It is noteworthy that the binding
of both target SNAREs decreased in parallel, confirming that
they exist in a binary complex and that it is this entity which is
capable of interacting with the C2B domain. To correlate the in
vitro and in vivo IP6 effects, we investigated the action of IP6 on
calcium-triggered exocytosis from digitonin-permeabilized
chromaffin cells. The catecholamine release exhibited high sen-
sitivity to acute application of IP6 with an IC50 of 16 M, a value
close to the IC50 for inhibition of the synaptotagmin/SNARE
interaction (Fig. 2B). It has been shown previously that the
cytoplasmic part of synaptotagmin I can bind to the plasma
membrane in resting cells (33). The single C2B domain alone
exhibited strong localization to the chromaffin cell plasma
membrane carrying the t-SNAREs, and this localization was
abolished in the presence of IP6 (Fig. 2C), suggesting that the
C2B domain may interact with t-SNARE dimers on the plasma
membrane.
Synaptotagmin II is distributed in neuronal tissues in a
complementary manner to synaptotagmin I, mainly in cerebel-
lum and in neuromuscular junctions, and is likely to act
through a similar mechanism in promoting vesicle exocytosis
(21, 27, 34–36). To test whether synaptotagmin II can interact
with SNAREs in vivo, we examined SNARE-interacting pro-
teins in rat whole-brain extract using an anti-SNAP-25 anti-
body covalently linked to Sepharose beads. After incubation of
these beads with the brain extract in the absence of calcium,
the bound proteins were analyzed by Western immunoblotting.
Staining for both syntaxin1 and SNAP-25 confirmed that these
two proteins interact in brain. Monoclonal antibodies specific
for synaptotagmin I (clone 41.1) and synaptotagmin II (27, 36)
identified 65-kDa bands co-purifying with the SNAREs on anti-
SNAP-25 beads but not on control beads lacking this antibody
(Fig. 3A). Staining for a control protein, calcineurin, confirmed
that co-isolation of the two synaptotagmin isoforms with the
SNAREs is of a specific nature. Washing of the brain-purified
synaptotagmin/SNARE assembly, using a salt solution, re-
FIG. 1. Calcium-independent interactions of the cytoplasmic
part of synaptotagmin I (C2AB) and the C2B domain with brain-
purified syntaxin (Syx) and SNAP-25. A, binding of Syx/SNAP-25 to
GST-C2AB of synaptotagmin I. 0.75 M NaCl disrupts the interaction of
GST-C2AB with the t-SNARE dimer (shown in Coomassie-stained gel).
B, electrostatic potentials of individual C2A and C2B domains of syn-
aptotagmin I (10 to 10 kT/e). Blue, positive charge; red, negative
charge. The domains are orientated with their calcium-binding loops
upwards. C, the polybasic motif is virtually identical among synapto-
tagmin I orthologs found in the animal kingdom. D, specific binding of
the t-SNARE dimer to the C2B but not the C2A domain. The total input
(left panel) and bound (center and right panels) proteins were analyzed
by SDS-PAGE followed by Coomassie staining. FIG. 2. Inositol hexakisphosphate (IP6) disrupts the synapto-
tagmin/SNARE link and inhibits catecholamine release. A, IP6
inhibits binding of the t-SNARE dimer to C2B of synaptotagmin I with
an IC50 of 6 M. Syntaxin and SNAP-25 binding to GST-C2B of synap-
totagmin I was performed in the presence of the indicated concentra-
tions of IP6. Inset, Coomassie-stained gel used to obtain densitometric
values. B, inhibition of Ca2-evoked catecholamine (CA) release from
permeabilized chromaffin cells by IP6 (IC50  16 M, n  4). C, local-
ization of GST-C2B of synaptotagmin I to the plasma membrane of
permeabilized chromaffin cells is disrupted by IP6. Endogenous
SNAP-25 and exogenous GST-C2B were visualized by double immuno-
fluorescence. Bound fluorescence was quantified for GST-C2B or GST,
used as a negative control (right, bar chart). *, p  0.0001.
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sulted in removal of both synaptotagmin I and II (Fig. 3A),
demonstrating the electrostatic nature of the synaptotagmin/
SNARE interactions for both isoforms. Together, these results
support the view that syntaxin and SNAP-25 interact in vivo
and, when assembled (11), these SNAREs can engage synap-
totagmins I and II through an electrostatic mechanism.
To confirm that the calcium-independent interaction of the
SNAREs with synaptotagmins does not require synaptobrevin
(18), we analyzed the two major synaptotagmin isoforms in a
reconstituted assay. The cytoplasmic part of synaptotagmin II
was indeed able to bind the t-SNARE dimer as efficiently as
synaptotagmin I, with an apparent equimolar stoichiometry
(Fig. 3B; Ref. 18). The polybasic motif is fully conserved be-
tween mammalian synaptotagmin I and synaptotagmin II (34).
To investigate the contribution of the basic residues in the
evolutionarily conserved motif, we analyzed the t-SNARE bind-
ing by synaptotagmin II C2B domains carrying mutations of
positively charged arginine and lysines to neutral glutamines
(Fig. 4A). The single-point mutations 5 and 6 resulted in the
largest decrease in the binding of the t-SNAREs (Fig. 4B). The
double mutation 5,6 had a more dramatic effect, and the triple
mutation 5,6,7 completely eliminated binding of the t-SNARE
dimer (Fig. 4B). Notably, these mutations have a parallel effect
on the binding of both syntaxin and SNAP-25 (Fig. 4C), again
illustrating that synaptotagmins recognize the syntaxin/
SNAP-25 dimer as a single molecular entity. We conclude that
the t-SNARE dimer interaction with synaptotagmins involves
the polybasic patch on the C2B domain.
A recent D. melanogaster genetic study demonstrated that
substitution of two lysine residues in the evolutionarily con-
served motif of synaptotagmin I, corresponding to mutations 5
and 6 (Fig. 4A), results in a marked decrease of excitation/
secretion coupling in neurotransmission (37). We decided to
test the importance of the polybasic motif of synaptotagmin I in
a model for mammalian exocytosis, namely in chromaffin cells
from bovine adrenal medullae (38). We chose to study primary
chromaffin cells rather than pheochromocytoma cell lines be-
cause PC12 cells exhibit normal exocytosis in the absence of
synaptotagmin I, most likely because of the presence of other
isoforms such as synaptotagmin IX (39, 40). In contrast, syn-
aptotagmin I-deficient chromaffin cells exhibit reduced exocy-
tosis, indicating a role for synaptotagmin I in calcium-triggered
hormone release (41). We analyzed the effect of expression of
the soluble synaptotagmin I cytoplasmic part in chromaffin
cells. If, indeed, synaptotagmin I, which is resident on secretory
vesicles, interacts with the syntaxin/SNAP-25 dimer on the
plasma membrane to promote vesicle fusion, then expression of
synaptotagmin I without its transmembrane part may affect
catecholamine release through competitive inhibition. We co-
transfected bovine chromaffin cells with the soluble synapto-
tagmin I C2AB and EGFP to tag the transfected cells. Carbon
fiber amperometry was used to measure catecholamine release
FIG. 3. Synaptotagmins I and II bind target SNAREs both in
vivo and in vitro. A, Sepharose beads with (anti-SNAP-25) or without
(control) covalently linked anti-SNAP-25 antibody were incubated in
the absence of calcium with rat brain Triton X-100 extract for 1 h and,
after extensive washing, were analyzed for bound proteins using West-
ern immunoblotting. Staining for a control protein, calcineurin, indi-
cates that co-isolation of the two synaptotagmin isoforms with syn-
taxin1 and SNAP-25 is of a specific nature. Washing with 0.75 M NaCl
removes synaptotagmins I and II from the SNAREs. B, GST-C2ABs of
synaptotagmins I and II attached to glutathione beads bind the t-
SNARE dimer in the absence of calcium. The original beads (left panel),
the total input of syntaxin and SNAP-25 (center panel), and bound
proteins (right panel) were analyzed by SDS-PAGE followed by Coo-
massie staining.
FIG. 4. Basic surface residues of the C2B domain are essential
for binding the t-SNARE dimer. A, mutational screen of the synap-
totagmin II C2B polybasic stretch. Mutated residues are numbered and
shown on the ribbon diagram. B, binding of t-SNAREs is plotted as a
percentage of the wild-type C2B (n  3). The wild-type and mutant
GST-C2B, immobilized on glutathione beads, were incubated with syn-
taxin and SNAP-25 for 30 min. After washing, bound SNAREs were
analyzed by immunoblotting and densitometry. Binding was normal-
ized to GST-C2B amounts in each reaction (lower panel, Coomassie-
stained gel). C, mutations 5,6 and 5,6,7 have a parallel effect on the
binding of both syntaxin and SNAP-25, thus demonstrating that C2B
recognizes both t-SNAREs as a single molecular entity.
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from single cells. Stimulation by a brief application of 0.003%
digitonin in the presence of 10 M Ca2 was used to directly
activate exocytosis, circumventing a requirement for calcium
channels. Expression of synaptotagmin I C2AB led to inhibi-
tion of regulated catecholamine release compared with control
non-transfected cells (Fig. 5A). Importantly, the amplitudes of
single release events were indistinguishable between the two
populations, whereas the number of spikes per cell was signif-
icantly decreased (Fig. 5A). This indicates that synaptotagmin
regulates the release probability rather than the amount of
transmitter releasable in a given fusion event, which is in
agreement with genetic studies of neurotransmission (7, 42).
We then introduced the double-point mutation K326A,
K327A, which is identical to that used in the D. melanogaster
study (37). Biochemical assays showed that this mutation se-
verely disrupted the ability of C2AB to bind the t-SNARE
dimer but did not compromise its calcium/phospholipid-binding
property (Fig. 5B). The normal phospholipid binding indicates
that the folding of the double C2 domain structure was unaf-
fected by the K326A,K327A mutation. When expressed in chro-
maffin cells, synaptotagmin I C2AB carrying this mutation was
no longer able to inhibit exocytosis (Fig. 5C), compared with the
wild-type C2AB (Fig. 5A). Therefore, we conclude that synap-
totagmin function in mammalian exocytosis involves the evo-
lutionarily conserved motif, which can mediate coupling to the
t-SNARE dimer.
DISCUSSION
The remarkable conservation of the polybasic motif in the
synaptotagmin C2B domain in Metazoan evolution indicates
that this region carries an essential physiological function (Fig.
2A). Indeed, it was recently demonstrated that mutation of two
lysine residues in the polybasic motif of D. melanogaster syn-
aptotagmin I decreases calcium-triggered neurotransmitter re-
lease (37). Several independent lines of evidence indicate that
the polybasic patch is essential for synaptotagmin interaction
with the t-SNARE dimer, and that this interaction may be
functionally important. First, mutations of specific lysine res-
idues in the C2B domain of synaptotagmins I and II disrupt
binding to the t-SNAREs (Figs. 4 and 5). Second, IP6, known to
interact with the polybasic stretch (24), competitively inhibits
the synaptotagmin/SNARE interaction, which is paralleled by
the inhibition of exocytosis in chromaffin cells (Fig. 2). Third,
inhibition of exocytosis by expressed soluble C2AB is abolished
by mutations within the polybasic region (Fig. 5). The location
of the polybasic stretch at a distance from the calcium/phos-
pholipid binding region can now explain why synaptotagmin
binding to the t-SNARE dimer is not linked to its calcium-
binding properties. Our finding of a direct molecular link be-
tween the t-SNARE dimer and synaptotagmin, through the
polybasic patch, provides a new explanation of how synapto-
tagmin mutations (37) can lead to a decrease in SNARE-medi-
ated exocytosis. It is conceivable that vesicular synaptotagmin
can position both syntaxin and SNAP-25 in close proximity to
the vesicular membrane, thus increasing the probability of
synaptobrevin engagement and thereby enhancing SNARE-
mediated membrane fusion.
Our study focused specifically at a calcium-independent prop-
erty of synaptotagmin, namely its proposed interaction with the
SNAREs (12–15). For synaptotagmins I and II, the major neuro-
nal isoforms, the SNARE-binding step may be essential for fur-
ther calcium-dependent actions. These actions may include syn-
aptotagmin binding to phospholipid membranes (23, 26, 42–44)
or a recently proposed phospholipid-induced oligomerization (45).
The in vivo competition assay used in our study could not test the
calcium-dependent phospholipid binding by the endogenous
synaptotagmin, most likely because of a large number of phos-
pholipid-binding sites. Indeed, expression of C2AB carrying
mutations of the calcium-coordinating residues in C2A
(D178N,D230N,D232N) and C2B (D363N,D365N) results in a
similar level of inhibition of catecholamine release, as for the
wild-type C2AB (data not shown). It is possible that the calcium/
phospholipid synaptotagmin action (42–44) is meaningful only
when synaptotagmin has the ability to interact with the syn-
taxin/SNAP-25 dimer during exocytosis.
The present work sheds a new light on two early studies into
the mechanisms underlying neurotransmitter release. First,
Bommert et al. (46) demonstrated that injection of peptides,
which include the conserved polybasic stretch, into squid giant
nerve terminals reversibly blocked transmitter release without
FIG. 5. C2AB inhibits exocytosis in chromaffin cells through
its polybasic motif. A, inhibition of evoked exocytosis in cells trans-
fected with the wild-type C2AB synaptotagmin I. Cumulative plot of
amperometric spikes after stimulation (indicated by the arrow); inset,
example traces from control and transfected cells. Bar chart at right
shows normalized number of spikes per cell after stimulation as a
percentage of control. *, p  0.02. B, K327,328A mutation in synapto-
tagmin I C2AB disrupts binding of the t-SNARE dimer (n  3) but not
calcium-triggered phospholipid binding (n  3). The wild-type and
mutant GST-C2AB attached to glutathione beads were tested for bind-
ing the t-SNARE dimer or fluorescent phospholipid liposomes. Bound
SNAREs were quantified with immunoblotting and expressed as a
percentage of the wild-type C2AB binding. C, the mutated K327,328A
C2AB is unable to inhibit evoked exocytosis. Cumulative plot of amper-
ometric spikes after stimulation (indicated by the arrow; inset, example
traces from control and transfected cells. Bar chart at right shows
normalized number of spikes per cell after stimulation as a percentage
of control.
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changing the vesicle population size. In the light of our results,
it is possible that the polybasic peptide interferes with synap-
totagmin/SNARE binding, resulting in a reversible blockade of
neurotransmission. Second, it was shown that injection of IP6
in the squid giant nerve terminals decreases vesicle release
probabilities by interfering with a late step of synaptic vesicle
exocytosis (32). Llinas et al. (32) predicted that IP6 specifically
disrupts synaptotagmin interaction with a molecular target
preceding membrane fusion. We reproduced in mammalian
cells the inhibition of vesicle exocytosis by IP6 and also dem-
onstrated that IP6 disrupts the synaptotagmin interaction with
the t-SNARE dimer over the same concentration range as for
inhibition of exocytosis (Fig. 2). These parallel effects are likely
due to the ability of IP6 to bind the polybasic patch (24), thus
impeding coupling of synaptotagmin to the t-SNARE dimer. It
now becomes necessary to investigate whether endogenous ino-
sitol polyphosphates and/or phosphoinositides can actually reg-
ulate synaptotagmin availability for the SNARE binding
(47, 48).
Although we favor the idea that the direct link of vesicular
synaptotagmin I to the target SNARE dimers on the plasma
membrane plays an important physiological role, as suggested
by current models (12–15), our present data do not exclude
other synaptotagmin interactions. Chapman et al. (49) origi-
nally implicated the C2B polybasic motif in three independent
functions: calcium-independent binding of the synprint peptide
and AP-2, and calcium-triggered oligomerization of C2 do-
mains. Recently, the calcium-triggered oligomerization has
been brought into doubt, as synaptotagmin I recombinant frag-
ments, after the removal of bacterial contaminants, no longer
oligomerize, as observed in the original study (31, 45). It re-
mains unclear, however, whether the reported synprint and
AP-2 binding can be reproduced by using the pure C2B domain.
It is unlikely that the in vivo data can be explained on the basis
of a possible link between synaptotagmin and AP-2 or calcium
channels that contain the synprint peptide. First, acute appli-
cation of IP6 inhibits vesicle exocytosis at a late step, which is
inconsistent with the possibility that replenishment of vesicle
pools by endocytosis is responsible for this inhibition of exocy-
tosis (Fig. 2; Ref. 32). Second, the use of calcium/digitonin in
our assays likely circumvents a need for a link between synap-
totagmin and calcium channels (Figs. 2 and 5). Importantly,
exocytosis in chromaffin cells, investigated here, does not seem
to rely on the association of secretory vesicles and calcium
channels (50, 51). An alternative interaction involving the po-
lybasic motif has recently been put forward by an electron
microscopy study (45), which reported calcium-induced homo-
oligomerization of recombinant synaptotagmin I fragments on
phospholipid membranes. The temporal and spatial relation-
ship between SNARE binding and synaptotagmin homo-oli-
gomerization during exocytosis remains to be addressed.
The existence of preassembled t-SNARE dimers on the
plasma membrane of chromaffin cells (11) suggests that they
may be a molecular target not only for synaptobrevin, but also
for synaptotagmin, in a sequence of events leading to exocyto-
sis. We now present the first evidence that the high affinity
interaction of synaptotagmin with the syntaxin/SNAP-25
dimer is driven by the hallmark signature sequence in the C2B
domain and that this interaction is sensitive to inositol
hexakisphosphate. Elucidation of the SNARE-binding motif on
synaptotagmin provides a new interpretation for previous in
vivo studies and will allow further experimentation on the
molecular mechanisms of secretory vesicle exocytosis.
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